Literature DB >> 7500917

Cellular receptor structures for pseudorabies virus are blocked by antithrombin III.

A Voigt1, D Sawitzky, H Zeichhardt, K O Habermehl.   

Abstract

Pseudorabies virus (PrV), an alphaherpesvirus of swine, uses cellular heparan sulfate residues as a receptor for attachment. Interaction of the virus with its receptor is mediated by the envelope glycoprotein C (PrV-gC), a protein with heparin-binding properties. We have previously shown that a region of this protein shows structural similarities to the high-affinity heparin-binding site of the serum protease-inhibitor antithrombin III (ATII). In this publication, we describe the effect of ATIII on interaction of PrV with its cellular receptor. ATIII bound specifically to heparan sulfate residues on the surface of herpesvirus-permissive RK13 cells. Binding of ATIII to RK13 cells interfered with adsorption of radioactively labelled PrV to these cells. Enzymatic treatment using heparinase I (E.C. 4.2.2.7) removed the receptor for PrV as well as the receptor for ATIII. Since amino acids 130-137 of the high affinity heparin-binding site of ATIII show structural similarities to amino acids 134-141 of PrV-gC, both sequences were synthesized as synthetic peptides. Although interaction of the peptide derived from ATIII with heparin was significantly stronger, both peptides interacted specifically with heparin in assays in vitro. These results suggest that PrV and ATIII interact with the same structure on the cellular surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500917     DOI: 10.1007/bf00221393

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  24 in total

1.  Initial interaction of herpes simplex virus with cells is binding to heparan sulfate.

Authors:  D WuDunn; P G Spear
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.

Authors:  M J Griffith
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

3.  Entry of pseudorabies virus into CHO cells is blocked at the level of penetration.

Authors:  D Sawitzky; H Hampl; K O Habermehl
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus.

Authors:  T C Mettenleiter; L Zsak; F Zuckermann; N Sugg; H Kern; T Ben-Porat
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

5.  Structure of heparin. Characterization of the products formed from heparin by the action of a heparinase and a heparitinase from Flavobacterium heparinum.

Authors:  M E Silva; C P Dietrich
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

6.  Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins.

Authors:  D Sawitzky; H Hampl; K O Habermehl
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

7.  A dot-blot assay for heparin-binding proteins.

Authors:  N Hirose; M Krivanek; R L Jackson; A D Cardin
Journal:  Anal Biochem       Date:  1986-08-01       Impact factor: 3.365

8.  Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus.

Authors:  A Karger; T C Mettenleiter
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

Review 9.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

10.  Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.

Authors:  M T Shieh; D WuDunn; R I Montgomery; J D Esko; P G Spear
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  2 in total

1.  Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.

Authors:  Roberta L Crim; Susette A Audet; Steven A Feldman; Howard S Mostowski; Judy A Beeler
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

2.  Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

Authors:  L K Hallak; D Spillmann; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.